| Who benefits when the government pays more? Pass-through in the Medicare Advantage program M Duggan, A Starc, B Vabson Journal of Public Economics 141, 50-67, 2016 | 153 | 2016 |
| The consequences of health care privatization: evidence from Medicare Advantage exits M Duggan, J Gruber, B Vabson American Economic Journal: Economic Policy 10 (1), 153-186, 2018 | 78* | 2018 |
| Health Care Rationing in Public Insurance Programs: Evidence from Medicaid TJ Layton, N Maestas, D Prinz, B Vabson American Economic Journal: Economic Policy 14 (4), 397-431, 2022 | 29* | 2022 |
| The behavioral foundations of default effects: theory and evidence from Medicare Part D ZC Brot-Goldberg, T Layton, B Vabson, AY Wang National Bureau of Economic Research, 2021 | 18 | 2021 |
| Rationing medicine through bureaucracy: authorization restrictions in medicare ZC Brot-Goldberg, S Burn, T Layton, B Vabson National Bureau of Economic Research, 2023 | 15 | 2023 |
| Efficiency Gains Under Incomplete Contracting: Evidence from Medicaid B Vabson Stanford Institute for Economic Policy Research Job Market Paper, 2017 | 6 | 2017 |
| Comparison of Care Quality Metrics in 2-Sided Risk Medicare Advantage vs Fee-for-Service Medicare Programs K Cohen, O Ameli, CE Chaisson, K Catlett, J Chiang, A Kwong, ... JAMA network open 5 (12), e2246064-e2246064, 2022 | 4 | 2022 |
| Predicting disability enrollment using machine learning T Layton, H Liebert, N Maestas, D Prinz, B Vabson NBER Working Paper No. NB18-Q4). National Bureau of Economic Research …, 2019 | 2 | 2019 |
| How Should Policymakers Respond To Growth In Cost Sharing That Often Goes Unpaid? B Ippolito, B Vabson Health Affairs Forefront, 2023 | 1 | 2023 |
| Essays in health economics and public finance B Vabson | 1 | 2014 |
| Rationing Medicine Through Bureaucracy: Authorization Restrictions in Medicare B Vabson, Z Brot-Goldberg, S Burn, T Layton AEI: American Enterprise Institute for Public Policy Research, 2023 | | 2023 |
| HPR24 Characteristics, Healthcare Resource Utilization, Cost, and Quality Outcomes of Medicare Beneficiaries While Commercially Insured and after Transition to Medicare … C Teigland, Z Pulungan, I Mohammadi, BT Jones, S Bilder, ... Value in Health 26 (6), S215, 2023 | | 2023 |
| The Impact Of Medicare Advantage Growth On Part D Competition, Costs, and Coverage B Ippolito, B Vabson Health Affairs Forefront, 2023 | | 2023 |
| The Value of Improving Insurance Quality: Evidence from Long-Run Medicaid Attrition A Lee, B Vabson Available at SSRN 4326229, 2023 | | 2023 |
| Medicaid v. Medicare—Evidence on Causal Program Differences from the Introduction of Part D TJ Layton, N Maestas, M Shepard, D Prinz, B Vabson 2020 APPAM Fall Research Conference, 2020 | | 2020 |
| Formulary Value Added D Prinz, TJ Layton, A Zink, B Vabson 2020 APPAM Fall Research Conference, 2020 | | 2020 |
Mark DugganProfessor of Economics, Stanford UniversityVerified email at stanford.edu
